Songmin He
Overview
Explore the profile of Songmin He including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
172
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai J, Zhu W, Lin Y, Hu J, Liu X, Xu W, et al.
Cancer Cell Int
. 2020 Dec;
20(1):532.
PMID: 33292203
Background: Viruses are obligate parasites that depend on host cells to provide the energy and molecular precursors necessary for successful infection. The main component of virus-induced metabolic reprogramming is the...
2.
Cai J, Zhu W, Lin Y, Zhang S, Chen X, Gong S, et al.
Hum Gene Ther
. 2020 Aug;
31(21-22):1203-1213.
PMID: 32829653
Oncolytic viruses are emerging as important tools for immunotherapy for cancer treatment; however, most of the clinically tested oncolytic candidates are still administered by intratumoral injection, and new viruses capable...
3.
Tang L, He S, Zhu Y, Feng B, Su Z, Liu B, et al.
J Cell Physiol
. 2019 Jan;
234(4):3661-3674.
PMID: 30607907
Psoriasis is a common chronic skin disease characterized by epidermal hyperplasia and inflammation. However, the pathogenesis of psoriasis is multifactorial and is not fully understood. MicroRNAs (miRNAs) represent a promising...
4.
Chen Z, He S, Zilberberg J, Lee W
Lab Chip
. 2018 Dec;
19(2):254-261.
PMID: 30547180
We report here a novel pumpless, 96-well plate-based platform for high-throughput dynamic multicellular culture and chemosensitivity evaluation. A gravity-driven flow strategy was developed to generate and sustain the flow rate...
5.
Liang J, Guo L, Li K, Xiao X, Zhu W, Zheng X, et al.
Nat Commun
. 2018 Apr;
9(1):1524.
PMID: 29670091
Oncolytic virus is an attractive anticancer agent that selectively lyses cancer through targeting cancer cells rather than normal cells. Although M1 virus is effective against several cancer types, certain cancer...
6.
Zhu Y, Feng B, He S, Su Z, Zheng G
Phytomedicine
. 2018 Mar;
40:20-26.
PMID: 29496171
Objective: To explore the preventive and therapeutic effects of Resveratrol combined with total flavones of hawthorn, compatibility of traditional Chinese medicines, on the endothelial cells injury after artery bypass graft...
7.
Tang L, He S, Wang X, Liu H, Zhu Y, Feng B, et al.
Exp Dermatol
. 2018 Feb;
27(3):268-275.
PMID: 29427477
The discovery of new therapeutic drugs with the efficacious and safe ability to prevent epidermal hyperplasia is extremely urgent for psoriasis. Cryptotanshinone (CTS), an active component isolated from the root...
8.
Tan Y, Lin Y, Li K, Xiao X, Liang J, Cai J, et al.
Hum Gene Ther
. 2017 Jul;
29(8):950-961.
PMID: 28750564
Oncolytic virotherapy is a novel and intriguing treatment strategy for cancer therapy. However, the clinical potential of oncolytic virus as single agent is limited. M1 virus is a promising oncolytic...
9.
He S, Zhu W, Zhou Y, Huang Y, Ou Y, Li Y, et al.
J Cell Biochem
. 2011 Apr;
112(9):2241-9.
PMID: 21480364
Malignant gliomas are the most common and lethal intracranial tumors, and differentiation therapy shows great potential to be a promising candidate for their treatment. Here, we have elaborated that a...
10.
Li Y, Lu H, Huang Y, Xiao R, Cai X, He S, et al.
Int J Cancer
. 2009 Nov;
127(6):1271-82.
PMID: 19882709
Malignant gliomas persist as a major disease of morbidity and mortality in adult. Differentiation therapy has emerged as a promising candidate modality. However, the mechanism related is unknown. Here, we...